C. Peyton, R. Dhanda, Tom Burke, Victoria Tsurutis, Nikky Ugwuoke, A. Nadkarni, Brent Burger, Veronica Lee, Michael J. Louie, A. Stover
2026.3.1Research and Reports in Urology
Resumen
Purpose This study aimed to evaluate the psychometric properties of the EORTC QLQ-NMIBC24 and to propose distribution-based minimal clinically important difference (MCID) thresholds in patients with low-grade, intermediate-risk NMIBC (LG-IR-NMIBC). Patients and Methods Patients with LG-IR-NMIBC from two phase 3 trials (ATLAS, n = 270; ENVISION, n = 240) completed the EORTC QLQ-C30 (ENVISION only) and QLQ-NMIBC24 questionnaires at baseline, Week 6, and Month 3. Psychometric evaluation of the QLQ-NMIBC24 in the LG-IR-NMIBC population included internal consistency, item convergence, known-groups validity, test-retest reliability and responsiveness to clinical change. Results Item-item (0.40–0.96) and item-scale correlations (0.44–0.96) indicated good convergent validity across most domains. Internal consistency was acceptable for all multi-item domains (Cronbach’s α 0.78–0.93) except Malaise, which showed lower reliability (Cronbach’s α 0.34–0.67). Known-groups comparisons supported the instrument’s ability to distinguish patients by physical function (effect sizes up to 1.63) and sex-related domains. Test-retest reliability was generally good for Urinary Symptoms and Sexual Function (ICC 0.79–0.82). Selected domains (Urinary Symptoms, Sexual Intimacy, Malaise) demonstrated responsiveness to clinical change. Distribution-based MCID estimates varied across domains (4.37–16.29), providing potential thresholds for meaningful changes in HRQoL scores. Anchor-based analyses using QLQ-C30 change scores were explored, but correlations with QLQ-NMIBC24 domains (r = –0.37 to 0.01) did not meet the minimum threshold (0.37). Conclusion The QLQ-NMIBC24 demonstrates valid, reliable, and interpretable measurement properties in patients with LG-IR-NMIBC. Although sensitivity varied across domains, the findings support its use in clinical trials and potentially routine practice. Distribution-based MCID thresholds provide guidance for interpreting meaningful HRQoL changes, though further studies using anchor-based methods are warranted.
Formato de cita
PEYTON, C., et al. Psychometric validation of the QLQ-NMIBC24 in low grade, intermediate risk non-muscle invasive bladder cancer. Research and Reports in Urology, 2026, 18: 1–14.